While alterations in other K<sub>2</sub>P channels, such as TREK-1, have been demonstrated in preclinical studies where reduced channel activity is associated with ischemia-reperfusion injury and promotes cardiac arrhythmias. This evidence concerns the gene KCNK2 and chronic obstructive pulmonary disease.